QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman

British Journal of Clinical Pharmacology

Volumn 66, Issue 6, 2008, Pages 896-897

  Asajima, Hiroshi ^a,c   Sekiguchi, Yohei ^a   Matsushima, Shoji ^a   Saito, Naotaka ^a   Saito, Takahiko ^b  

^a HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

^b Kitami Red Cross Hospital   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; SOLIFENACIN;

AGED; CASE REPORT; CONSCIOUSNESS DISORDER; CREATININE CLEARANCE; ECG ABNORMALITY; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; LETTER; LIVER FUNCTION; OVERACTIVE BLADDER; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SYNCOPE; TORSADE DES POINTES; TREATMENT FAILURE;

AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MUSCARINIC ANTAGONISTS; QUINUCLIDINES; SYNCOPE; TETRAHYDROISOQUINOLINES; TORSADES DE POINTES; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE;

EID: 56549129347     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03298.x     Document Type: Letter

References (7)

1. Payne CK. Solifenacin in overactive bladder syndrome. Drugs 2006 66 : 175 90.
2. Connolly MJ, Astridge PS, White EG, Morley CA, Cowan JC. Torsades de pointes ventricular tachycardia and terodiline. Lancet 1991 33 : 344 5.
3. McLeod AA, Thorogood S, Barnett S. Torsades de pointes complicating treatment with terodiline. BMJ 1991 302 : 1469.
4. Dmochowski R, Staskin DR. The QT interval and antimuscarinic drugs. Curr Urol Rep 2005 6 : 405 9.
5. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004 350 : 1013 22.
6. Gupta A, Lawrence AT, Krisnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007 153 : 819 99.
7. Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992 22 : 22 31.